Next Article in Journal
Fabrication and Characterization of an Optimized Low-Loss Two-Mode Fiber for Optoacoustic Sensing
Next Article in Special Issue
Application Prospects of MXenes Materials Modifications for Sensors
Previous Article in Journal
A Novel Capacitorless 1T DRAM with Embedded Oxide Layer
Previous Article in Special Issue
Enhanced Gas Sensing Performance of ZnO/Ti3C2Tx MXene Nanocomposite
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Micromachines
Volume 13
Issue 10
10.3390/mi13101773
micromachines-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Advanced MXene-Based Micro- and Nanosystems for Targeted Drug Delivery in Cancer Therapy

by
Fatemeh Mohajer
1,
Ghodsi Mohammadi Ziarani
1,*,
Alireza Badiei
2,
Siavash Iravani
3 and
Rajender S. Varma
4,*
1
Department of Organic Chemistry, Faculty of Chemistry, Alzahra University, Tehran 19938-93973, Iran
2
School of Chemistry, College of Science, University of Tehran, Tehran 14176-14411, Iran
3
Faculty of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan 81746-73461, Iran
4
Regional Centre of Advanced Technologies and Materials, Czech Advanced Technology and Research Institute, Palacký University in Olomouc, Šlechtitelů 27, 783 71 Olomouc, Czech Republic
*
Authors to whom correspondence should be addressed.
Micromachines 2022, 13(10), 1773; https://doi.org/10.3390/mi13101773
Submission received: 13 September 2022 / Revised: 13 October 2022 / Accepted: 17 October 2022 / Published: 19 October 2022
(This article belongs to the Special Issue Rise of MXenes: A New Family of Two-Dimensional (2D) Materials and Devices)
Browse Figures
Versions Notes

Abstract

:
MXenes with unique mechanical, optical, electronic, and thermal properties along with a specific large surface area for surface functionalization/modification, high electrical conductivity, magnetic properties, biocompatibility, and low toxicity have been explored as attractive candidates for the targeted delivery of drugs in cancer therapy. These two-dimensional materials have garnered much attention in the field of cancer therapy since they have shown suitable photothermal effects, biocompatibility, and luminescence properties. However, outstanding challenging issues regarding their pharmacokinetics, biosafety, targeting properties, optimized functionalization, synthesis/reaction conditions, and clinical translational studies still need to be addressed. Herein, recent advances and upcoming challenges in the design of advanced targeted drug delivery micro- and nanosystems in cancer therapy using MXenes have been discussed to motivate researchers to further investigate this field of science.

1. Introduction

Today, the development of nanotechnology has resulted in the creation of several multidisciplinary research domains, namely bionanotechnology, with special contributions in biomedicine and cancer nanomedicine [1,2,3,4,5,6]. An assortment of nanoparticles and nanoarchitectures has been designed with satisfactory biocompatibility and targeting properties for a wide range of biomedical and clinical applications; however, due to the stringent regulatory necessities, only a handful of them have entered into clinical trials/studies. Nevertheless, these materials have garnered widespread attention from scientists for their deployment as anticancer nanocarriers and nanobiosensors [7,8,9,10,11,12].
Chiral peptide/protein-derived supramolecules with biological activities can assist in prevention and treatment of various diseases, especially cancers [13]. Biomedicine entails ground-breaking supplies and technologies for specific therapeutics. Traditional policies are not in favor relative to modern medicine due to vital shortcomings, such as nonexact targeting, as well as the absence of synergistic attributes, wherein the booming development of nanotechnologies brings forth a fresh outlook to the biomedicine arena [14,15,16]. In this context, the design of nanomaterials with therapeutic and diagnostic potential has been widely noticed by researchers. For instance, two-dimensional (2D) hexagonal boron nitride (2D h-BN) flatlands have garnered much attention due to the optical and physicochemical properties, outstanding thermal/chemical constancy, and biocompatibility [17,18], showing excellent potential in biomedicine [19].
On the other hand, with the discovery of graphene [20], transition metal dichalcogenides (e.g., TiS2, MoS2, and WS2) [21,22,23], black phosphorus nanosheets [24], layered double hydroxides [25], graphitic carbon nitride [26], boron nitride [27], metal–organic frameworks [28], and transition metal oxides [29], among others, a variety of advanced micro- and nanosystems have been designed for cancer therapy. Recently, MXenes, 2D material comprising transition metal carbides, nitrides or carbonitrides, have captured widespread attention in photothermal therapy (PTT) in view of the high light-to-heat conversion efficiency, elevated paramagnetic performance, and large specific surface area [30,31,32]. However, MXene photothermal agents (PTAs) are unstable in aqueous/oxidative surroundings as their terminal functional groups (–F, –OH, or –O) are vulnerable to oxidation and tend to aggregate in physiological solutions; although, after suitable modification/functionalization, the stability and properties of these structures can be improved [33].
Among the recently introduced materials, MXenes are two-dimensional (2D) transition metal carbides and nitrides with a vast surface area and hydrophilicity, which have been explored in biomedical engineering and medicine [34,35,36]. They have swiftly become popular for a range of study domains due to their outstanding features since Yury Gogotsi and colleagues synthesized the first family member in 2011 [37]. Although MXenes are a relatively young family of 2D materials, the number of scientific articles connected to them nearly doubles every year [30,38,39,40,41].
Two-dimensional MXenes are contemporary 2D transition metal carbides, which resemble graphene sheets comprising the formula Mn+1XnTx (e.g., Ti3C2Tx). Exfoliation of the “A” layer from a “MAX” predecessor—where M, A, and X indicate the transition metal, elements from IIIA or IVA, and N, respectively—can be used to make these materials, depending on their situation and type of applications. Among widely developed methods deployed for the manufacturing of MXenes comprise urea glass (e.g., Mo2C and Mo2N) [42], chemical vapor deposition (e.g., Mo2C) [43], molten salt etching (e.g., Ti4N3Tx) [44], hydrothermal fabrication (e.g., Ti3C2Tx) [45], and electrochemical synthesis (e.g., Ti2CTx). The wet etching method, in particular, may be utilized to create them in good quality with largely hydrophilic properties [46]. MXenes and their derivatives can be applied for photothermal and photodynamic cancer therapy [47]. These materials with unique optical properties have been explored in the field of (bio)imaging and (bio)sensing [48,49,50]. On the other hand, routinely applied anticancer drugs for chemotherapy may suffer from low specificity/selectivity, high toxicity, off-target toxic effects, and inappropriate clearance. Designing multifunctional systems with high biocompatibility, specificity/selectivity, biodistribution, and bioavailability can help to improve the efficiency of cancer therapy and tumor ablation. MXene-based micro- and nanosystems have been applied for targeted delivery of anticancer drugs/therapeutic agents in cancer therapy after surface functionalization/modification by bioactive/biocompatible agents (Figure 1) [51,52].
In addition, long-acting therapeutic anticancer drugs may cause possible toxic effects on normal cells along with a low efficacy in cancer therapy [53,54,55]. Low bioavailability of conventional chemotherapy, with some drawbacks, such as possible side effects, high dose requirements, and multidrug resistance, have prompted researchers to find new solutions based on drug delivery micro- and nanosystems with the benefits of higher solubility, specific targeting, high biocompatibility, selectivity, and reduced toxicity [56,57]. Conventional organics with biodegradable attributes and strong biocompatibility have been extensively studied for clinical applications, but their poor thermal and chemical stability and low functionality are some of the obstacles limiting their clinical developments [58]. In this context, MXene-based nanostructures have unveiled a variety of clinical and biomedical potential owing to their unique physicochemical properties, such as ease of functionalization, tunable structures, biosafety, and physiological constancy [59]. However, crucial aspects of toxicity and biocompatibility ought to be further explored. The potential toxicity of MXenes has been investigated throughout the embryonic and angiogenesis phases, wherein they have revealed negative impacts during the early stages of embryogenesis [58]; about 46% of MXene-exposed embryos died within 15 days [60]. MXenes were shown to impede the angiogenesis of the embryo’s chorioallantoic membrane after 5 days at the tested dosages. When compared to the controls, several genes were deregulated in the liver tissues and brain of embryos treated with MXene; nevertheless, further research and analysis are warranted to comprehend the potential toxicity of MXenes [60,61]. The biosafety of MXenes can be improved by applying suitable functionalization and hybridization techniques using biocompatible and biodegradable agents (e.g., cellulose and chitosan) along with optimized reaction/synthesis conditions.
The key applications of MXenes in biomedicine comprise, among others, (bio)imaging, tissue engineering, (bio)sensing, cancer therapy/diagnosis, and drug delivery [62,63]. Properties of MXenes can be improved by using suitable hybridization techniques, providing MXenes with improved thickness and compactness of the silane film, uniformity, good density, and fewer flaws [64,65]; wherever conductivity is essential for interaction with electromagnetic waves, interference shielding may exploit appropriate magnetic dipoles. Additionally, 2D MXenes ranging from metallic to semiconductor can detect adjustable conductivity; 2D MXenes with hydrophilicity ought to be manufactured using cost-effective methods [64]. Their layered structures, on the other hand, are likely to hinder the creation of gaps, which may change their magnetic and electric characteristics. As a result, unfavorable effects on the electromagnetic interference activity of composites made from MXenes are not unlikely. This significant disadvantage could be resolved by synergistic interactions amongst MXenes and conducting/magnetic materials [64,66].
Studies on these materials expose the need of controlling their physicochemical characteristics through surface charge engineering for novel biotechnological and biomedical applications [67]. For cancer therapy and tissue-engineering purposes, MXene-based micro- and nanosystems offer adjustable mechanical properties, excellent photothermal conversion efficiency, targeting competence, biocompatibility, selectivity, and regulated drug discharge [68]. For instance, composite hydrogels based on Ti3C2 MXene and cellulose have been engineered to respond quickly to near-infrared (NIR)-stimulated features. These manufactured hydrogels modified with doxorubicin (DOX) hydrochloride exhibited exceptional drug release acceleration and could be employed as nanoplatforms for intratumoral cancer therapy [68].

2. Advanced MXene-Based Micro- and Nanosystems

2.1. Structural, Chemical, and Electronic Properties of MXenes

MXenes have functional groups such as F, OH, and O after its exfoliation from the MAX phase where the O- and/or OH- terminated groups are the most stable, as F group will be substituted with OH groups on rinsing and storing in H2O [69]. Xie et al. stated that OH groups could be transformed into O terminations over high-temperature and/or metal adsorption procedures [69]. In addition, O-terminated MXene could decompose into bare MXene up on interaction with Mg, Ca, Al, or other metals [70]. Modeling is crucial in designing MXenes with novel structures [71]. Surface groups are located above the hollow sites among three near C atoms [72,73]. The precise configurations of surface groups depend on both, their species and the MXene’s constituent materials [74]. MXenes have many usage such as, electronic [75], dielectric [76], magnetic [77,78,79,80], elastic [81], thermoelectric [82], and optical properties [83] as has been documented by computational studies. Bare MXene, such as Tin+1Xn, are known to be metallic in behavior [83]. In terms of X atoms, titanium nitrides exhibit more metallic properties than titanium carbides, simply because the N atom possesses one more electron than the C atom [84]. In terms of the chemical properties of MXenes, Naguib et al. reported that Ti3C2Tx are oxidized in air, CO2, or pressurized water [85] wherein the oxidation results in the formation of anatase TiO2 nanocrystals embedded in amorphous carbon sheets (TiO2-C hybrid structure).
One of interesting topics in the progression of theranostic nanomedicines for in vivo clinical studies is the finding of association among the physicochemical nature of the designed structures and their connections with living organizations. Therefore, experimental studies are necessary to assess the productivity, toxic effects, and their physio-chemical properties. Comprehensive preclinical studies and the assessment of the biological interactions of MXenes and their complexes in in vivo systems could support to find their limits in the future [86].
MXenes are important due to their widespread applications as supercapacitors [87], in electromagnetic interference shielding [88], optical and light detection [89], and even in communication and biology [90]. The optical properties of MXenes have displayed the possibility of producing electrodes [90], photonic devices and plasmonic applications [91]. Furthermore, biocompatible MXene (Ti3C2)-based composites (MnOx/Ti3C2) were applied for cancer theranostics, nanoplatform for photothermal cancer/tumor nanotherapy by photoacoustic imaging [92].

2.2. MXene-Based Biomimetic Plasmonic Method

An effective plasmonic-enhanced technique has been presented and used for biomimetic photo-induced plasmonic assembly (NPD@M). Nb2C plasmon (MXene), Pt nanozymes, DOX, and tumor cytomembrane make up the assemblage for targeted cancer therapy. The hot-electrons created from MXene after homogeneous targeting and internalization into cancer cells notably promote the catalase-like and oxidase-like functions of Pt nanozymes to generate O2 and reactive oxygen species (ROS), combined with tumor-penetrating photothermal therapy. DOX is also released in acidic conditions, aided by O2 and ROS-induced suppression of P-glycoprotein (P-gp)-mediated drug efflux [93]. These results demonstrated that MXene-augmented nanozyme therapy decreased the HeLa cell viability by 38.67% when compared to control cells; nanozyme catalytic activity was improved by the hot-electron oscillations from Nb2C by NIR-II laser to kill tumors. NPD@M was inserted into the body by the tail vein so that it could enter the tumor through the EPR effect and tumor cytomembrane targeting while the NIR-II light illumination and photothermal possessions expanded tumor vessels to improve the blood pressure to a drug eruption. The nanozyme activity was boosted by the plasmon thermoplastic result. Using a high concentration of H2O2 high (100 μM~1 mM) in the tumor results in down-regulation of the hypoxia-inducible factor (HIF-1α). Concurrently, the heightened oxidase endorses ROS production which reduces the mitochondrial energy source to P-gp glycoprotein, while a membrane efflux pump recognizes the chemotherapeutic drugs for transporting out of cells. This process counters multidrug resistance and recovers the chemotherapy effectiveness. Collectively, biomimetic plasmonic assembly completes the tumor treatment by irradiation of NIR-II, as a novel strategy to promote the nanozyme biocatalyst and plasmonic application in tumors (Figure 2) [94].

2.3. MXene/DOXjade Platforms

For synergistic cancer therapy, Ti3C2-PVP@DOXjade, a pH-responsive dual-therapeutic compound based on deferasirox and DOX, was created wherein photo-irradiation with Ti3C2-PVP@DOXjade displayed a pH-responsive iron chelation/PTT/chemotherapy anticancer activity [95]. Cancer cells have a high requirement for iron with important roles in cell proliferation, tumor growth, and metastasis thus rendering iron metabolism a promising therapeutic target. Unfortunately, existing iron-based therapy techniques are frequently ineffective and have side effects. The prodrug combines deferasirox (ExJade®), a therapeutically authorized iron chelator, with DOX, a topoisomerase 2 inhibitor (DOX). DOXjade was loaded onto ultrathin 2D Ti3C2 MXene nanosheets to create Ti3C2-PVP@DOXjade, which allows DOXjade’s iron chelation and chemotherapeutic functions to be photo-activated at tumor sites, additionally potentiating a robust photothermal effect with photothermal conversion efficiencies up to 40%. Ti3C2-PVP@DOXjade promotes apoptotic cell death and down-regulates the iron depletion-induced iron transferrin receptor, according to antitumor mechanistic studies as iron chelation/photothermal/chemotherapy responds to the pH of the tumor [95].
Two-dimensional ultrathin Ti3C2 MXene nanosheets were predicted to react with DOXjade in this setting. The ensuing construct, known as Ti3C2-PVP@DOXjade, was projected to have high photothermal efficiency [96]. Indeed, when exposed to NIR light at 808 nm inside the optical-therapeutic window (650–900 nm), Ti3C2 nanosheets included in Ti3C2-PVP@DOXjade demonstrated photothermal conversion efficiencies up to 40% and bestowed a good PTT performance [97,98]. Furthermore, Ti3C2-PVP@DOXjade flaunted a sensitive tumor pH-responsive iron chelation/PTT/chemotherapy anticancer impact. To remove the Al layer, Ti3AlC2 Max phase crystals were etched in an aqueous HF solution to generate Ti3C2 which was treated with an aqueous tetrapropylammonium hydroxide (TPAOH) solution and after agitation, the multilayer Ti3C2 nanosheets were formed. MXenes nanosheets and PVP (polyvinylpyrrolidone) were mixed in phosphate-buffered saline to afford Ti3C2-PVP; notably, the DOXjade was produced via the modification of DOX to offer hydrazones [99]. In phosphate-buffered saline (PBS) at pH = 7.4, DOXjade was loaded on Ti3C2-PVP under an argon atmosphere to afford DOXjade-loaded Ti3C2-PVP (Figure 3 and Figure 4).

2.4. Ti3C2 Nanosheet-Based Camouflaged Bionic Cascaded-Enzyme Nanoreactor

The use of enzymes to generate ROS at tumor locations has emerged as a new technique for controlling intracellular redox states in anticancer therapy. The Ti3C2 nanosheet-based camouflaged bionic cascaded-enzyme nanoreactor has been applied for combined tumor enzyme dynamic treatment (EDT), phototherapy, and deoxygenation-activated chemotherapy [100]. The deoxygenation-activated drug tirapazamine (TPZ) was loaded onto Ti3C2 nanosheets, glucose oxidase (GOX), and chloroperoxidase (CPO) to furnish Ti3C2-GOX-CPO/TPZ (TGCT) which was implanted into nanosized cancer cell-derived membrane vesicles with high-expressed CD47 (meTGCT). The cascade reaction of GOX and CPO, into tumor cells, might create HClO for the effective EDT. Simultaneously, additional laser irradiation would speed up the enzymic-catalytic reaction rate and boost singlet oxygen production (1O2). A local hypoxic environment combined with EDT-induced oxygen depletion activates a deoxygenation-sensitive prodrug for treatment. Therefore, the synergistic therapeutic benefits of tumor phototherapy, EDT, and chemotherapy are increased in meTGCT. This cascaded-enzyme nanoreactor affords a good method to bring in anticancer treatment (Figure 5A) [100]. TGCT nanocascaded enzymes were created through the reaction of GOX and CPO onto Ti3C2 nanosheets with TPZ drug loading and the biomimetic alteration of CD47-overexpressed cancer cell membrane offer a bionic cascaded-enzyme nanoreactor (as meTGCT). MeTGCT was affected by tumor cells and the enzyme consumes glucose and oxygen in tumor areas to generate the lethal HClO. Under NIR laser irradiation, Ti3C2 may create both, heat, and ROS, where heat can speed up the enzyme-catalyzed reaction rate and ROS generation, exacerbating the hypoxic state in the target tumor environment (TME). Then, as a hypoxia-activated prodrug, TPZ is activated by reductase, causing DNA breakage and cell death, thus enhancing EDT and phototherapy effects. As a result, hypoxia-activated chemotherapy may achieve magnified synergistic effects in this camouflaged cascaded-enzyme nanoreactor, effectively inhibiting tumor development [100] (Figure 5B).

2.5. Few-Layered Nb2C (FNC) for Osteoclastogenesis Suppression Inhibited Inflammation and Osteoclastogenesis

Implant-derived particulates, such as ultra-high molecular-weight polyethylene (UHMWPE), activate the immune system to phagocytose particles, resulting in the production of ROS [101]. ROS stimulates osteoclast genesis and causes macrophages to release cytokines, which aid in the progression of osteolysis. The few-layered Nb2C (FNC) is an antioxidant with the ability to reduce cytokine production and inhibit osteoclast genesis by ROS adsorption. Furthermore, in a mouse calvarial model, local injection of a few-layered Nb2C (FNC) reduces UHMWPE and induced osteolysis. As a result, it has been demonstrated that FNC could be beneficial in the treatment of osteolytic bone disease encouraged by excessive osteoclast genesis. In this process, the reaction of Nb2AlC, LiF, and HCl provided bulk Nb2C (BNC) which was treated with tetrapropylammonium hydroxide (TPAOH) to offer FNC. The ensuing product (few-layered Nb2C) was washed with DI water, centrifuged, and dried. It was demonstrated that FNC was effective in scavenging ROS for treating ROS-related diseases via FNC adsorption of ROS in the process of osteoclast genesis suppression in vitro. Furthermore, the findings displayed that osteolysis was condensed in vivo when UHMWPE was stimulated (Figure 6) [101].

2.6. Advanced Systems Based on Ti3C2 MXenes

Titanium carbide (Ti3C2) MXenes were developed by surface modification in the presence of antioxidants (sodium ascorbate, SA, and dopamine, DA) to obtain (DA/SA@Ti3C2 = DSTC) [33]. Antioxidants improved the MXenes stability by trapping oxidants and the MXenes functionalization process with biotic molecules, therefore glucose oxidase (GOx) and photosensitizer (chlorin e6 = Ce6 PS) were attached to the DSTC surface through the carbodiimide link to provide Ce6/GOx@SDTC = CGDSTC). It was applied for glucose deprivation and photodynamic therapy for the co-killing of cancer cells. Increasing the solution temperature by laser irradiation boosted the enzymatic activity of CGDSTC nanosheets. These nanosheets exhibited cytocompatibility to HePG2 and HeLa cells; it was established that 90% of cells were killed by glucose and laser irradiation through the cooperative outcome between famine therapy and phototherapy. The possible mechanisms of synthesized CGDSTC nanosheets are illustrated in Figure 7A [33]. Glucose-rich environments provide gluconic acid in the tumor by GOx, subsequently sensitizing the tumor cells to photothermal properties by limiting the tumor glycolytic path. Photo irradiation with 808 and 671 nm lasers participates in tumor cell destruction by supporting Ti3C2- mediated PTT and Ce6-mediated PDT properties; higher temperature produces tumor oxygen levels alongside with GOx. Accordingly, synthesized CGDSTC nanosheets by starvation and phototherapy, remove the tumor cells more safely. The enzyme (GOx) and photosensitizer (Ce6) were sequentially conjugated onto the DSTC nanosheets via carbodiimide coupling between the carboxyl groups and amine groups of DSTC nanosheets to attain CGDSTC nanosheets with photodynamic and starvation properties (Figure 7B) [33].
Through the fluorescence imaging, MXene-based multifunctional nanosheets were developed to expand high cancer therapeutic efficacy via the cooperative effect. The stability of Ti3C2 MXene was improved by surface modification with the antioxidants such as sodium ascorbate (SA) and dopamine (DA) to offer DA/SA@Ti3C2 (abbreviated as DSTC).

2.7. MXene Quantum Dot/ZIF-Based Systems for Anticancer Drug Delivery

Designing novel stimuli-responsive multifunctional structures for targeted drug delivery in cancer therapy has been studied [102,103]. For instance, zeolitic imidazolate framework-8 (ZIF-8) with a large and precise surface expanse, encapsulates DOX and MXene quantum dot (MQD) to furnish MQD@ZIF-8/DOX with high photothermal conversion efficacy and ROS generation ability to provide excellent photothermal therapy and photodynamic therapy effects. In addition, DOX was loaded into MQD@ZIF-8 nanoparticles which released the DOX at pH 5.6. Multifunctional MQD@ZIF-8 drug delivery is illustrated in Figure 8, where Zn2+ was immobilized on MQD as nucleation nodes. MQD@ZIF-8 composites were synthesized in situ via the rapid reaction between Zn2+ and 2-MIM molecules. The anticancer drug, DOX, was encapsulated in MQD@ZIF-8 where MQD served as PTA and PS in this system to realize combined PDT/PTT therapy, which rapidly converted NIR light energy to ablative heat and generated ROS under UV laser irradiation to kill cancer cells. Moreover, DOX release could be markedly increased under the tumor environment. The MQD@ZIF-8/DOX nanocarrier can therefore achieve the effect of combined chemotherapy and phototherapy during tumor treatment [102,103].
Multifunctional MQD@ZIF-8 drug delivery system was prepared by instantaneously capturing MQD with phototherapeutic potential and the chemotherapeutic drug DOX in a ZIF-8 environment. The MQD@ZIF-8 nanocarrier had a modest preparation and proficiently linked pH with NIR dual responsiveness to excite the drug release. Through the cell test, it was illustrated that MQD@ZIF-8 had a greater biocompatibility, and MQD@ZIF-8 could produce temperature and ROS around cells under 808 nm laser and UV irradiation for killing HeLa cells, individually. Thus, MQD@ZIF-8 could be considered as a suitable platform with superb tumor therapeutic potential.

2.8. Ionic Liquid-Exfoliated Ti3C2Tx MXene ((IL)-Ti3C2Tx MXene) Nanosheets in Cancer Treatment

Ti3C2Tx MXenes with potential activity in cancer treatment were produced through an ionic liquid (IL) stripping process; DOX was loaded into (IL)-Ti3C2Tx MXene to provide composites with pH-responsive behavior and photosensitivity with enhanced drug release upon 808 nm laser irradiation [104]. These nanocomposites exhibited high chemical stability and good biocompatibility. They could inhibit tumor growth using synergistic photothermal therapy and chemotherapy; photoacoustic imaging has great potential in cancer treatment (Figure 9) [104].
IL-supported exfoliation of the MXene phase could provide few-layer IL-Ti3C2Tx Under 808 nm laser irradiation, the IL-Ti3C2Tx MXene nanosheets exhibited high chemical stability and robust near-infrared absorption, with suitable photothermal conversion efficiency. The IL-Ti3C2Tx MXene nanosheets could be applied for targeted delivery of DOX with pH-/photosensitivity; the drug release was enhanced in an acidic situation under the laser irradiation (808 nm). These nanosheets displayed good photothermal effects on 4T1 cells under 808 nm (in vitro) to obtain the decent photoacoustic image. Furthermore, they exhibited appropriate antitumor properties (in vitro and in vivo). Thus, these MXene-based systems can be considered for photoacoustic imaging and synergistic photothermal/chemotherapy of cancer with high efficiency [104].

2.9. MXene@Au-Polyethylene Glycol Composites Drug Release

MXene@Au-polyethylene glycol composites have been developed as targeted drug delivery systems with a high capacity for loading chemotherapeutic agents (DOX) [105]; these nanosystems exhibited both NIR laser-triggered and pH-responsive drug release modes [106]. Owing to surface modification with thiol polyethylene glycol aldehyde chains (SH-PEG-CHO) connected to the MXene by Au nanoparticles, the system showed improved photothermal stability, biosafety, and histocompatibility during in vivo and in vitro tests. In addition, based on the good photothermal conversion capability of both Au nanomaterials and MXenes, these nanosystems exhibited synergistic photothermal ablation and chemotherapy for tumor/cancer therapy. Their passively targeted release properties also enhanced the cellular uptake of DOX at tumor sites, thus improving the efficiency of the drug. Future explorations ought to move towards designing surface-modified MXene-based drug delivery platforms with high drug-loading capacity, multiple drug release modes, and synergistic therapy, offering new opportunities for targeted cancer therapy and tumor ablation (Figure 10) [106].
A variety of MXene-based micro-and nano systems have been designed for targeted cancer therapy (Table 1).

3. Conclusions and Perspectives

MXenes, with their intrinsic physicochemical features and superb biocompatibility, have acquired a lot of interest in wide-ranging biological and biomedical applications. By managing preparative constraints, external features could be modified for cancer therapeutics and diagnostics. MXene-based micro- and nanosystems can be applied for targeted delivery of anticancer drugs/therapeutic agents, with the advantages of low toxicity and good biocompatibility. However, the improvement of biocompatibility, pharmacokinetics, and biodegradability of these structures ought to be focused comprehensively; discovering simple, cost-effective, and environmentally benign synthesis/functionalization approaches, optimized synthesis/reaction conditions, and efficient hybridization uniting biocompatible/biodegradable agents, are the key parameters in improving the properties and effectiveness of MXene-based systems. The verification of successful absorption of therapeutic chemicals from the circulation into the desired location is a key challenge in systemic disposition. The vascular endothelial cell, which acts as an obstacle between organs and blood, is one of the most important concerns. Endothelial cells’ cellular acceptance of manmade nanosystems is thus critical for their biological and therapeutic applications. MXene-based composites can be functionalized or modified utilizing appropriate functional groups/agents to enhance their loading capacity, biocompatibility, and bioavailability. This strategy can also be adopted to reduce undesirable/adverse side effects as well as probable immune system reactions. MXene-based materials for targeted drug delivery in cancer therapy would continue their fast progress made in less than half a decade in the future at a rapid pace. Hopefully, the analyses and outlook directions offered in this review can guide scientists and engineers to focus on the development of MXenes and their derivatives for targeted drug delivery and cancer therapy.

Author Contributions

F.M.: writing—review and editing, draw graphical abstract; G.M.Z.: project administration, supervision, writing—review and editing; A.B.: writing—review and editing, supervision; S.I.: writing—review and editing; R.S.V.: writing—review and editing, supervision. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Data Availability Statement

Not applicable.

Acknowledgments

We acknowledge the Research Council of Alzahra University.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Barry, N.P.E.; Sadler, P.J. Challenges for Metals in Medicine: How Nanotechnology May Help To Shape the Future. ACS Nano 2013, 7, 5654–5659. [Google Scholar] [CrossRef]
  2. Iravani, S.; Soufi, G.J. Gold Nanostructures in Medicine and Biology. In Nanoparticles in Medicine; Springer: Berlin/Heidelberg, Germany, 2020; pp. 175–183. [Google Scholar]
  3. Iravani, S.; Varma, R.S. Greener synthesis of lignin nanoparticles and their applications. Green Chem. 2020, 22, 612–636. [Google Scholar] [CrossRef]
  4. Iravani, S.; Varma, R.S. Green synthesis, biomedical and biotechnological applications of carbon and graphene quantum dots. A Review. Environ. Chem. Lett. 2020, 18, 703–727. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Mohammadi Ziarani, G.; Mofatehnia, P.; Mohajer, F.; Badiei, A. Rational design of yolk–shell nanostructures for drug delivery. RSC Adv. 2020, 10, 30094–30109. [Google Scholar] [CrossRef] [PubMed]
  6. Mohajer, F.; Mohammadi Ziarani, G.; Badiei, A. New advances on Au–magnetic organic hybrid core–shells in MRI, CT imaging, and drug delivery. RSC Adv. 2021, 11, 6517–6525. [Google Scholar] [CrossRef]
  7. Soufi, G.J.; Iravani, S. Eco-friendly and sustainable synthesis of biocompatible nanomaterials for diagnostic imaging: Current challenges and future perspectives. Green Chem. 2020, 22, 2662–2687. [Google Scholar] [CrossRef]
  8. Alavi, M.; Varma, R.S. Phytosynthesis and modification of metal and metal oxide nanoparticles/nanocomposites for antibacterial and anticancer activities: Recent advances. Sustain. Chem. Pharm. 2021, 21, 100412. [Google Scholar] [CrossRef]
  9. Shafiee, A.; Iravani, S.; Varma, R.S. Graphene and graphene oxide with anticancer applications: Challenges and future perspectives. MedComm 2022, 3, e118. [Google Scholar] [CrossRef]
  10. Delfi, M.; Sartorius, R.; Ashrafizadeh, M.; Sharifi, E.; Zhang, Y.; De Berardinis, P.; Zarrabi, A.; Varma, R.S.; Tay, F.R.; Smith, B.R.; et al. Self-assembled peptide and protein nanostructures for anti-cancer therapy: Targeted delivery, stimuli-responsive devices and immunotherapy. Nano Today 2021, 38, 101119. [Google Scholar] [CrossRef]
  11. Rabiee, N.; Bagherzadeh, M.; Ghadiri, A.M.; Fatahi, Y.; Aldhaher, A.; Makvandi, P.; Dinarvand, R.; Jouyandeh, M.; Saeb, M.R.; Mozafari, M.; et al. Turning Toxic Nanomaterials into a Safe and Bioactive Nanocarrier for Co-delivery of DOX/pCRISPR. ACS Appl. Bio Mater. 2021, 4, 5336–5351. [Google Scholar] [CrossRef]
  12. Rabiee, N.; Bagherzadeh, M.; Jouyandeh, M.; Zarrintaj, P.; Saeb, M.R.; Mozafari, M.; Shokouhimehr, M.; Varma, R.S. Natural Polymers Decorated MOF-MXene Nanocarriers for Co-delivery of Doxorubicin/pCRISPR. ACS Appl. Bio Mater. 2021, 4, 5106–5121. [Google Scholar] [CrossRef] [PubMed]
  13. Yan, J.; Yao, Y.; Yan, S.; Gao, R.; Lu, W.; He, W. Chiral Protein Supraparticles for Tumor Suppression and Synergistic Immunotherapy: An Enabling Strategy for Bioactive Supramolecular Chirality Construction. Nano Lett. 2020, 20, 5844–5852. [Google Scholar] [CrossRef] [PubMed]
  14. Kim, H.; Beack, S.; Han, S.; Shin, M.; Lee, T.; Park, Y.; Kim, K.S.; Yetisen, A.K.; Yun, S.H.; Kwon, W.; et al. Multifunctional Photonic Nanomaterials for Diagnostic, Therapeutic, and Theranostic Applications. Adv. Mater. 2018, 30, 1701460. [Google Scholar] [CrossRef] [PubMed]
  15. Song, S.; Shen, H.; Wang, Y.; Chu, X.; Xie, J.; Zhou, N.; Shen, J. Biomedical application of graphene: From drug delivery, tumor therapy, to theranostics. Colloids Surf. B 2020, 185, 110596. [Google Scholar] [CrossRef]
  16. Qian, X.; Gu, Z.; Chen, Y. Two-dimensional black phosphorus nanosheets for theranostic nanomedicine. Mater. Horiz. 2017, 4, 800–816. [Google Scholar] [CrossRef]
  17. Angizi, S.; Alem, S.A.A.; Azar, M.H.; Shayeganfar, F.; Manning, M.I.; Hatamie, A.; Pakdel, A.; Simchi, A. A comprehensive review on planar boron nitride nanomaterials: From 2D nanosheets towards 0D quantum dots. Prog. Mater. Sci. 2022, 124, 100884. [Google Scholar] [CrossRef]
  18. Chen, Y.; Wang, L.; Shi, J. Two-dimensional non-carbonaceous materials-enabled efficient photothermal cancer therapy. Nano Today 2016, 11, 292–308. [Google Scholar] [CrossRef]
  19. Gong, L.; Yan, L.; Zhou, R.; Xie, J.; Wu, W.; Gu, Z. Two-dimensional transition metal dichalcogenide nanomaterials for combination cancer therapy. J. Mater. Chem. B 2017, 5, 1873–1895. [Google Scholar] [CrossRef]
  20. Novoselov, K.S.; Geim, A.K.; Morozov, S.V.; Jiang, D.; Zhang, Y.; Dubonos, S.V.; Grigorieva, I.V.; Firsov, A.A. Electric field effect in atomically thin carbon films. Science 2004, 306, 666–669. [Google Scholar] [CrossRef] [Green Version]
  21. Qian, X.; Shen, S.; Liu, T.; Cheng, L.; Liu, Z. Two-dimensional TiS2 nanosheets for in vivo photoacoustic imaging and photothermal cancer therapy. Nanoscale 2015, 7, 6380–6387. [Google Scholar] [CrossRef]
  22. Wang, J.; Sui, L.; Huang, J.; Miao, L.; Nie, Y.; Wang, K.; Yang, Z.; Huang, Q.; Gong, X.; Nan, Y.; et al. MoS2-based nanocomposites for cancer diagnosis and therapy. Bioact. Mater. 2021, 6, 4209–4242. [Google Scholar] [CrossRef] [PubMed]
  23. Manisekaran, R.; García-Contreras, R.; Rasu Chettiar, A.-D.; Serrano-Díaz, P.; Lopez-Ayuso, C.A.; Arenas-Arrocena, M.C.; Hernández-Padrón, G.; López-Marín, L.M.; Acosta-Torres, L.S. 2D Nanosheets—A New Class of Therapeutic Formulations against Cancer. Pharmaceutics 2021, 13, 1803. [Google Scholar] [CrossRef] [PubMed]
  24. Liu, H.; Mei, Y.; Zhao, Q.; Zhang, A.; Tang, L.; Gao, H.; Wang, W. Black Phosphorus, an Emerging Versatile Nanoplatform for Cancer Immunotherapy. Pharmaceutics 2021, 13, 1344. [Google Scholar] [CrossRef] [PubMed]
  25. Wen, J.; Yang, K.; Huang, J.; Sun, S. Recent advances in LDH-based nanosystems for cancer therapy. Mater. Des. 2021, 198, 109298. [Google Scholar] [CrossRef]
  26. Liu, C.; Qin, H.; Kang, L.; Chen, Z.; Wang, H.; Qiu, H.; Ren, J.; Qu, X. Graphitic carbon nitride nanosheets as a multifunctional nanoplatform for photochemical internalization-enhanced photodynamic therapy. J. Mater. Chem. B 2018, 6, 7908–7915. [Google Scholar] [CrossRef] [PubMed]
  27. Ciofani, M.E.; Şen, Ö.; Çulha, M. Hexagonal Boron Nitride Nanoparticles for Prostate Cancer Treatment. ACS Appl. Nano Mater. 2020, 3, 2364–2372. [Google Scholar] [CrossRef]
  28. Saeb, M.R.; Rabiee, N.; Mozafari, M.; Verpoort, F.; Voskressensky, L.G.; Luque, R. Metal–Organic Frameworks (MOFs) for Cancer Therapy. Materials 2021, 14, 7277. [Google Scholar] [CrossRef]
  29. Pandey, N.; Dhiman, S.; Srivastava, T.; Majumder, S. Transition metal oxide nanoparticles are effective in inhibiting lung cancer cell survival in the hypoxic tumor microenvironment. Chem. Biol. Interact. 2016, 254, 221–230. [Google Scholar] [CrossRef]
  30. Pogorielov, M.; Smyrnova, K.; Kyrylenko, S.; Gogotsi, O.; Zahorodna, V.; Pogrebnjak, A. MXenes—A New Class of Two-Dimensional Materials: Structure, Properties and Potential Applications. Nanomaterials 2021, 11, 3412. [Google Scholar] [CrossRef]
  31. Dai, C.; Chen, Y.; Jing, X.; Xiang, L.; Yang, D.; Lin, H.; Liu, Z.; Han, X.; Wu, R. Two-Dimensional Tantalum Carbide (MXenes) Composite Nanosheets for Multiple Imaging-Guided Photothermal Tumor Ablation. ACS Nano 2017, 11, 12696–12712. [Google Scholar] [CrossRef]
  32. Han, X.; Huang, J.; Lin, H.; Wang, Z.; Li, P.; Chen, Y. 2D Ultrathin MXene-Based Drug-Delivery Nanoplatform for Synergistic Photothermal Ablation and Chemotherapy of Cancer. Adv. Healthc. Mater. 2018, 7, e1701394. [Google Scholar] [CrossRef] [PubMed]
  33. Korupalli, C.; You, K.-L.; Getachew, G.; Rasal, A.S.; Dirersa, W.B.; Zakki Fahmi, M.; Chang, J.-Y. Engineering the Surface of Ti3C2 MXene Nanosheets for High Stability and Multimodal Anticancer Therapy. Pharmaceutics 2022, 14, 304. [Google Scholar] [CrossRef] [PubMed]
  34. Karthikeyan, P.; Elanchezhiyan, S.S.; Preethi, J.; Talukdar, K.; Meenakshi, S.; Park, C.M. Two-dimensional (2D) Ti3C2Tx MXene nanosheets with superior adsorption behavior for phosphate and nitrate ions from the aqueous environment. Ceram. Int. 2020, 47, 732–739. [Google Scholar] [CrossRef]
  35. Iravani, S.; Varma, R.S. MXenes in cancer nanotheranostics. Nanomaterials 2022, 12, 3360. [Google Scholar] [CrossRef]
  36. Zhang, Y.-Z.; El-Demellawi, J.K.; Jiang, Q.; Ge, G.; Liang, H.; Lee, K.; Dong, X.; Alshareef, H.N. MXene hydrogels: Fundamentals and applications. Chem. Soc. Rev. 2020, 49, 7229–7251. [Google Scholar] [CrossRef]
  37. Naguib, M.; Kurtoglu, M.; Presser, V.; Lu, J.; Niu, J.; Heon, M.; Hultman, L.; Gogotsi, Y.; Barsoum, M.W. Two-Dimensional Nanocrystals Produced by Exfoliation of Ti3AlC2. Adv. Mater. 2011, 23, 4248–4253. [Google Scholar] [CrossRef] [Green Version]
  38. Jamalipour Soufi, G.; Iravani, P.; Hekmatnia, A.; Mostafavi, E.; Khatami, M.; Iravani, S. MXenes and MXene-based Materials with Cancer Diagnostic Applications: Challenges and Opportunities. Comments Inorg. Chem. 2021, 42, 174–207. [Google Scholar] [CrossRef]
  39. Nguyen, T.P.; Nguyen, D.M.T.; Le, H.K.; Vo, D.-V.N.; Lam, S.S.; Varma, R.S.; Shokouhimehr, M.; Nguyen, C.C.; Van Le, Q. MXenes: Applications in electrocatalytic, photocatalytic hydrogen evolution reaction and CO2 reduction. Mol. Catal. 2020, 486, 110850. [Google Scholar] [CrossRef]
  40. Malaki, M.; Maleki, A.; Varma, R.S. MXenes and ultrasonication. J. Mater. Chem. A 2019, 7, 10843–10857. [Google Scholar] [CrossRef]
  41. Eid, K.; Lu, Q.; Abdel-Azeim, S.; Soliman, A.; Abdullah, A.M.; Abdelgwad, A.M.; Forbes, R.P.; Ozoemena, K.I.; Varma, R.S.; Shibl, M.F. Highly exfoliated Ti3C2Tx MXene nanosheets atomically doped with Cu for efficient electrochemical CO2 reduction: An experimental and theoretical study. J. Mater. Chem. A 2022. [Google Scholar] [CrossRef]
  42. Ma, L.; Ting, L.R.L.; Molinari, V.; Giordano, C.; Yeo, B.S. Efficient hydrogen evolution reaction catalyzed by molybdenum carbide and molybdenum nitride nanocatalysts synthesized via the urea glass route. J. Mater. Chem. A 2015, 3, 8361–8368. [Google Scholar] [CrossRef]
  43. Xu, C.; Wang, L.; Liu, Z.; Chen, L.; Guo, J.; Kang, N.; Ma, X.-L.; Cheng, H.-M.; Ren, W. Large-area high-quality 2D ultrathin Mo2C superconducting crystals. Nat. Mater. 2015, 14, 1135–1141. [Google Scholar] [CrossRef] [PubMed]
  44. Urbankowski, P.; Anasori, B.; Makaryan, T.; Er, D.; Kota, S.; Walsh, P.L.; Zhao, M.; Shenoy, V.B.; Barsoum, M.W.; Gogotsi, Y. Synthesis of two-dimensional titanium nitride Ti4N3 (MXene). Nanoscale 2016, 8, 11385–11391. [Google Scholar] [CrossRef] [PubMed]
  45. Li, T.; Yao, L.; Liu, Q.; Gu, J.; Luo, R.; Li, J.; Yan, X.; Wang, W.; Liu, P.; Chen, B. Fluorine-free synthesis of high-purity Ti3C2Tx (T = OH, O) via alkali treatment. Angew. Chem. Int. Ed. 2018, 57, 6115–6119. [Google Scholar] [CrossRef]
  46. Sun, W.; Shah, S.; Chen, Y.; Tan, Z.; Gao, H.; Habib, T.; Radovic, M.; Green, M. Electrochemical etching of Ti2AlC to Ti2CTx (MXene) in low-concentration hydrochloric acid solution. J. Mater. Chem. A 2017, 5, 21663–21668. [Google Scholar] [CrossRef]
  47. Iravani, S.; Varma, R.S. MXenes in photomedicine: Advances and prospects. ChemComm 2022, 58, 7336–7350. [Google Scholar] [CrossRef]
  48. Iravani, S.; Varma, R.S. MXenes for Cancer Therapy and Diagnosis: Recent Advances and Current Challenges. ACS Biomater. Sci. Eng. 2021, 7, 1900–1913. [Google Scholar] [CrossRef]
  49. Kuang, P.; Low, J.; Cheng, B.; Yu, J.; Fan, J. MXene-based photocatalysts. J. Mater. Sci. Technol. 2020, 56, 18–44. [Google Scholar] [CrossRef]
  50. Wang, C.; Wang, Y.; Jiang, X.; Xu, J.; Huang, W.; Zhang, F.; Liu, J.; Yang, F.; Song, Y.; Ge, Y.; et al. MXene Ti3C2Tx: A Promising Photothermal Conversion Material and Application in All-Optical Modulation and All-Optical Information Loading. Adv. Opt. Mater. 2019, 7, 1900060. [Google Scholar] [CrossRef]
  51. Hendijani, F. Human mesenchymal stromal cell therapy for prevention and recovery of chemo/radiotherapy adverse reactions. Cytotherapy 2015, 17, 509–525. [Google Scholar] [CrossRef]
  52. Pardoll, D.M. The blockade of immune checkpoints in cancer immunotherapy. Nat. Rev. Cancer 2012, 12, 252–264. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  53. Chari, R.V.J. Targeted Cancer Therapy: Conferring Specificity to Cytotoxic Drugs. Acc. Chem. Res. 2007, 41, 98–107. [Google Scholar] [CrossRef] [PubMed]
  54. Murugan, C.; Sharma, V.; Murugan, R.K.; Malaimegu, G.; Sundaramurthy, A. Two-dimensional cancer theranostic nanomaterials: Synthesis, surface functionalization and applications in photothermal therapy. J. Control. Release 2019, 299, 1–20. [Google Scholar] [CrossRef] [PubMed]
  55. Shi, Z.; Zhou, Y.; Fan, T.; Lin, Y.; Zhang, H.; Mei, L. Inorganic nano-carriers based smart drug delivery systems for tumor therapy. Smart Mater. Med. 2020, 1, 32–47. [Google Scholar] [CrossRef]
  56. Jain, V.; Jain, S.; Mahajan, S. Nanomedicines Based Drug Delivery Systems for Anti-Cancer Targeting and Treatment. Curr. Drug Deliv. 2015, 12, 177–191. [Google Scholar] [CrossRef]
  57. Iravani, P.; Iravani, S.; Varma, R.S. MXene-chitosan composites and their biomedical potentials. Micromachines 2022, 13, 1383. [Google Scholar] [CrossRef]
  58. Lin, H.; Chen, Y.; Shi, J. Insights into 2D MXenes for Versatile Biomedical Applications: Current Advances and Challenges Ahead. Adv. Sci. 2018, 5, 1800518. [Google Scholar] [CrossRef] [Green Version]
  59. George, S.M.; Kandasubramanian, B. Advancements in MXene-Polymer composites for various biomedical applications. Ceram. Int. 2019, 46, 8522–8535. [Google Scholar] [CrossRef]
  60. Alhussain, H.; Augustine, R.; Hussein, E.A.; Gupta, I.; Hasan, A.; Al Moustafa, A.-E.; Elzatahry, A. MXene Nanosheets May Induce Toxic Effect on the Early Stage of Embryogenesis. J. Biomed. Nanotechnol. 2020, 16, 364–372. [Google Scholar] [CrossRef]
  61. Iravani, S.; Varma, R.S. Bioinspired and biomimetic MXene-based structures with fascinating properties: Recent advances. Mater. Adv. 2022, 3, 4783–4796. [Google Scholar] [CrossRef]
  62. Huang, H.; Dong, C.; Feng, W.; Wang, Y.; Huang, B.; Chen, Y. Biomedical engineering of two-dimensional MXenes. Adv. Drug Deliv. Rev. 2022, 184, 114178. [Google Scholar] [CrossRef] [PubMed]
  63. Zamhuri, A.; Lim, G.P.; Ma, N.L.; Tee, K.S.; Soon, C.F. MXene in the lens of biomedical engineering: Synthesis, applications and future outlook. Biomed. Eng. Online 2021, 20, 33. [Google Scholar] [CrossRef] [PubMed]
  64. Shukla, V. Review of electromagnetic interference shielding materials fabricated by iron ingredients. Nanoscale Adv. 2019, 1, 1640–1671. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  65. Zhan, X.; Si, C.; Zhou, J.; Sun, Z. MXene and MXene-based composites: Synthesis, properties and environment-related applications. Nanoscale Horiz. 2019, 5, 235–258. [Google Scholar] [CrossRef]
  66. Verger, L.; Xu, C.; Natu, V.; Cheng, H.-M.; Ren, W.; Barsoum, M.W. Overview of the synthesis of MXenes and other ultrathin 2D transition metal carbides and nitrides. Curr. Opin. Solid State Mater. Sci. 2019, 23, 149–163. [Google Scholar] [CrossRef]
  67. Rozmysłowska-Wojciechowska, A.; Mitrzak, J.; Szuplewska, A.; Chudy, M.; Woźniak, J.; Petrus, M.; Wojciechowski, T.; Vasilchenko, A.S.; Jastrzębska, A.M. Engineering of 2D Ti3C2 MXene Surface Charge and its Influence on Biological Properties. Materials 2020, 13, 2347. [Google Scholar] [CrossRef]
  68. Xing, C.; Chen, S.; Liang, X.; Liu, Q.; Qu, M.; Zou, Q.; Li, J.; Tan, H.; Liu, L.; Fan, D.; et al. Two-Dimensional MXene (Ti3C2)-Integrated Cellulose Hydrogels: Toward Smart Three-Dimensional Network Nanoplatforms Exhibiting Light-Induced Swelling and Bimodal Photothermal/Chemotherapy Anticancer Activity. ACS Appl. Mater. Interfaces 2018, 10, 27631–27643. [Google Scholar] [CrossRef]
  69. Xie, Y.; Naguib, M.; Mochalin, V.N.; Barsoum, M.W.; Gogotsi, Y.; Yu, X.; Nam, K.-W.; Yang, X.-Q.; Kolesnikov, A.I.; Kent, P.R. Role of Surface Structure on Li-Ion Energy Storage Capacity of Two-Dimensional Transition-Metal Carbides. J. Am. Chem. Soc. 2014, 136, 6385–6394. [Google Scholar] [CrossRef]
  70. Xie, Y.; Dall’Agnese, Y.; Naguib, M.; Gogotsi, Y.; Barsoum, M.W.; Zhuang, H.L.; Kent, P.R.C. Prediction and Characterization of MXene Nanosheet Anodes for Non-Lithium-Ion Batteries. ACS Nano 2014, 8, 9606–9615. [Google Scholar] [CrossRef]
  71. Hu, T.; Wang, J.; Zhang, H.; Li, Z.; Hu, M.; Wang, X. Vibrational properties of Ti3C2and Ti3C2T2(T = O, F, OH) monosheets by first-principles calculations: A comparative study. Phys. Chem. Chem. Phys. 2015, 17, 9997–10003. [Google Scholar] [CrossRef]
  72. Tang, Q.; Zhou, Z.; Shen, P. Are MXenes Promising Anode Materials for Li Ion Batteries? Computational Studies on Electronic Properties and Li Storage Capability of Ti3C2 and Ti3C2X2 (X = F, OH) Monolayer. J. Am. Chem. Soc. 2012, 134, 16909–16916. [Google Scholar]
  73. Khazaei, M.; Arai, M.; Sasaki, T.; Chung, C.-Y.; Venkataramanan, N.S.; Estili, M.; Sakka, Y.; Kawazoe, Y. Novel Electronic and Magnetic Properties of Two-Dimensional Transition Metal Carbides and Nitrides. Adv. Funct. Mater. 2012, 23, 2185–2192. [Google Scholar] [CrossRef]
  74. Wang, X.; Shen, X.; Gao, Y.; Wang, Z.; Yu, R.; Chen, L. Atomic-Scale Recognition of Surface Structure and Intercalation Mechanism of Ti3C2X. J. Am. Chem. Soc. 2015, 137, 2715–2721. [Google Scholar] [CrossRef] [PubMed]
  75. Enyashin, A.N.; Ivanovskii, A.L. Two-dimensional titanium carbonitrides and their hydroxylated derivatives: Structural, electronic properties and stability of MXenes Ti3C2−xNx(OH)2 from DFTB calculations. J. Solid State Chem. 2013, 207, 42–48. [Google Scholar] [CrossRef] [Green Version]
  76. Mauchamp, V.; Bugnet, M.; Bellido, E.P.; Botton, G.A.; Moreau, P.; Magne, D.; Naguib, M.; Cabioc’h, T.; Barsoum, M.W. Enhanced and tunable surface plasmons in two-dimensional Ti3C2 stacks: Electronic structure versus boundary effects. Phys. Rev. B 2014, 89, 235428. [Google Scholar] [CrossRef]
  77. Shein, I.R.; Ivanovskii, A.L. Planar nano-block structures Tin+1Al0.5Cn and Tin+1Cn (n = 1, and 2) from MAX phases: Structural, electronic properties and relative stability from first principles calculations. Superlattices Microstruct. 2012, 52, 147–157. [Google Scholar] [CrossRef]
  78. Shein, I.R.; Ivanovskii, A.L. Graphene-like titanium carbides and nitrides Tin+1Cn, Tin+1Nn (n = 1, 2, and 3) from de-intercalated MAX phases: First-principles probing of their structural, electronic properties and relative stability. Comput. Mater. Sci. 2012, 65, 104–114. [Google Scholar] [CrossRef]
  79. Xie, Y.; Kent, P.R.C. Hybrid density functional study of structural and electronic properties of functionalized Tin+1Xn (X = C, N) monolayers. Phys. Rev. B 2013, 87, 235441. [Google Scholar] [CrossRef] [Green Version]
  80. Zhao, S.; Kang, W.; Xue, J. Manipulation of electronic and magnetic properties of M2C (M = Hf, Nb, Sc, Ta, Ti, V, Zr) monolayer by applying mechanical strains. Appl. Phys. Lett. 2014, 104, 133106. [Google Scholar] [CrossRef] [Green Version]
  81. Wang, S.; Li, J.-X.; Du, Y.-L.; Cui, C. First-principles study on structural, electronic and elastic properties of graphene-like hexagonal Ti2C monolayer. Comput. Mater. Sci. 2014, 83, 290–293. [Google Scholar] [CrossRef]
  82. Khazaei, M.; Arai, M.; Sasaki, T.; Estili, M.; Sakka, Y. Two-dimensional molybdenum carbides: Potential thermoelectric materials of the MXene family. Phys. Chem. Chem. Phys. 2014, 16, 7841–7849. [Google Scholar] [CrossRef] [PubMed]
  83. Lashgari, H.; Abolhassani, M.R.; Boochani, A.; Elahi, S.M.; Khodadadi, J. Electronic and optical properties of 2D graphene-like compounds titanium carbides and nitrides: DFT calculations. Solid State Commun. 2014, 195, 61–69. [Google Scholar] [CrossRef]
  84. Enyashin, A.N.; Ivanovskii, A.L. Structural and Electronic Properties and Stability of MXenes Ti2C and Ti3C2 Functionalized by Methoxy Groups. J. Phys. Chem. C 2013, 117, 13637–13643. [Google Scholar] [CrossRef]
  85. Naguib, M.; Mashtalir, O.; Lukatskaya, M.R.; Dyatkin, B.; Zhang, C.; Presser, V.; Gogotsi, Y.; Barsoum, M.W. One-step synthesis of nanocrystalline transition metal oxides on thin sheets of disordered graphitic carbon by oxidation of MXenes. Chem. Commun. 2014, 50, 7420–7423. [Google Scholar] [CrossRef] [Green Version]
  86. Johnson, K.K.; Koshy, P.; Yang, J.L.; Sorrell, C.C. Preclinical Cancer Theranostics—From Nanomaterials to Clinic: The Missing Link. Adv. Funct. Mater. 2021, 31, 2104199. [Google Scholar] [CrossRef]
  87. Ghidiu, M.; Lukatskaya, M.R.; Zhao, M.-Q.; Gogotsi, Y.; Barsoum, M.W. Conductive two-dimensional titanium carbide ‘clay’ with high volumetric capacitance. Nature 2014, 516, 78–81. [Google Scholar] [CrossRef]
  88. Shahzad, F.; Alhabeb, M.; Hatter, C.B.; Anasori, B.; Man Hong, S.; Koo, C.M.; Gogotsi, Y. Electromagnetic interference shielding with 2D transition metal carbides (MXenes). Science 2016, 353, 1137–1140. [Google Scholar] [CrossRef] [Green Version]
  89. Montazeri, K.; Currie, M.; Verger, L.; Dianat, P.; Barsoum, M.W.; Nabet, B. Beyond Gold: Spin-Coated Ti3C2-Based MXene Photodetectors. Adv. Mater. 2019, 31, 1903271. [Google Scholar] [CrossRef]
  90. Naguib, M.; Mochalin, V.N.; Barsoum, M.W.; Gogotsi, Y. Two-dimensional materials: 25th anniversary article: MXenes: A new family of two-dimensional materials (Adv. Mater. 7/2014). Adv. Mater. 2014, 26, 982. [Google Scholar] [CrossRef]
  91. Dillon, A.D.; Ghidiu, M.J.; Krick, A.L.; Griggs, J.; May, S.J.; Gogotsi, Y.; Barsoum, M.W.; Fafarman, A.T. Highly Conductive Optical Quality Solution-Processed Films of 2D Titanium Carbide. Adv. Funct. Mater. 2016, 26, 4162–4168. [Google Scholar] [CrossRef]
  92. Dai, C.; Lin, H.; Xu, G.; Liu, Z.; Wu, R.; Chen, Y. Biocompatible 2D titanium carbide (MXenes) composite nanosheets for pH-responsive MRI-guided tumor hyperthermia. Chem. Mater. 2017, 29, 8637–8652. [Google Scholar] [CrossRef]
  93. Loo, T.W.; Clarke, D. Recent Progress in Understanding the Mechanism of P-Glycoprotein-mediated Drug Efflux. J. Membr. Biol. 2005, 206, 173–185. [Google Scholar] [CrossRef] [PubMed]
  94. Hao, Z.; Li, Y.; Liu, X.; Jiang, T.; He, Y.; Zhang, X.; Cong, C.; Wang, D.; Liu, Z.; Gao, D. Enhancing biocatalysis of a MXene-based biomimetic plasmonic assembly for targeted cancer treatments in NIR-II biowindow. Chem. Eng. J. 2021, 425, 130639. [Google Scholar] [CrossRef]
  95. Xu, Y.; Wang, Y.; An, J.; Sedgwick, A.C.; Li, M.; Xie, J.; Hu, W.; Kang, J.; Sen, S.; Steinbrueck, A.; et al. 2D-ultrathin MXene/DOXjade platform for iron chelation chemo-photothermal therapy. Bioact. Mater. 2021, 14, 76–85. [Google Scholar] [CrossRef] [PubMed]
  96. Lin, H.; Wang, X.; Yu, L.; Chen, Y.; Shi, J. Two-Dimensional Ultrathin MXene Ceramic Nanosheets for Photothermal Conversion. Nano Lett. 2017, 17, 384–391. [Google Scholar] [CrossRef]
  97. Li, M.; Shao, Y.; Kim, J.H.; Pu, Z.; Zhao, X.; Huang, H.; Xiong, T.; Kang, Y.; Li, G.; Shao, K.; et al. Unimolecular Photodynamic O2-Economizer To Overcome Hypoxia Resistance in Phototherapeutics. J. Am. Chem. Soc. 2020, 142, 5380–5388. [Google Scholar] [CrossRef]
  98. Li, M.; Xiong, T.; Du, J.; Tian, R.; Xiao, M.; Guo, L.; Long, S.; Fan, J.; Sun, W.; Shao, K.; et al. Superoxide Radical Photogenerator with Amplification Effect: Surmounting the Achilles’ Heels of Photodynamic Oncotherapy. J. Am. Chem. Soc. 2019, 141, 2695–2702. [Google Scholar] [CrossRef]
  99. Gupta, P.; Jat, K.; Solanki, V.S.; Shrivastava, R. Synthesis and Antimicrobial Activity of some New N′-Arylidene-4-(3, 5-Bis (2-Hydroxyphenyl)-1H-1, 2, 4-Triazole-1-yl) Benzohydrazides. Indian J. Heterocycl. Chem. 2017, 27, 151–156. [Google Scholar]
  100. Zhang, X.; Cheng, L.; Lu, Y.; Tang, J.; Lv, Q.; Chen, X.; Chen, Y.; Liu, J. A MXene-Based Bionic Cascaded-Enzyme Nanoreactor for Tumor Phototherapy/Enzyme Dynamic Therapy and Hypoxia-Activated Chemotherapy. Nano-Micro Lett. 2021, 14, 22. [Google Scholar] [CrossRef]
  101. Sun, K.-Y.; Wu, Y.; Xu, J.; Xiong, W.; Xu, W.; Li, J.; Sun, Z.; Lv, Z.; Wu, X.S.; Jiang, Q.; et al. Niobium carbide (MXene) reduces UHMWPE particle-induced osteolysis. Bioact. Mater. 2022, 8, 435–448. [Google Scholar] [CrossRef]
  102. Feng, X.; Li, M.; Wang, J.; Zou, X.; Wang, H.; Wang, D.; Zhou, H.; Yang, L.; Gao, W.; Liang, C. MXene Quantum Dot/Zeolitic Imidazolate Framework Nanocarriers for Dual Stimulus Triggered Tumor Chemo-Phototherapy. Materials 2022, 15, 4543. [Google Scholar] [CrossRef] [PubMed]
  103. Liu, J.; Qiao, S.Z.; Chen, J.S.; Lou, X.W.D.; Xing, X.; Lu, G.Q.M. Yolk/shell nanoparticles: New platforms for nanoreactors, drug delivery and lithium-ion batteries. Chem. Commun. 2011, 47, 12578–12591. [Google Scholar] [CrossRef] [PubMed]
  104. Lu, B.; Hu, S.; Wu, D.; Wu, C.; Zhu, Z.; Hu, L.; Zhang, J. Ionic liquid exfoliated Ti3C2Tx MXene nanosheets for photoacoustic imaging and synergistic photothermal/chemotherapy of cancer. J. Mater. Chem. B 2022, 10, 1226–1235. [Google Scholar] [CrossRef] [PubMed]
  105. Hanušová, V.; Boušová, I.; Skálová, L. Possibilities to increase the effectiveness of doxorubicin in cancer cells killing. Drug Metab. Rev. 2011, 43, 540–557. [Google Scholar] [CrossRef]
  106. Liu, A.; Liu, Y.; Liu, G.; Zhang, A.; Cheng, Y.; Li, Y.; Zhang, L.; Wang, L.; Zhou, H.; Liu, J.; et al. Engineering of surface modified Ti3C2Tx MXene based dually controlled drug release system for synergistic multitherapies of cancer. Biochem. Eng. J. 2022, 448, 137691. [Google Scholar] [CrossRef]
Micromachines 13 01773 g001 550
Figure 1. MXenes and their derivatives with versatile biomedical potentials.
Figure 1. MXenes and their derivatives with versatile biomedical potentials.
Micromachines 13 01773 g001
Micromachines 13 01773 g002 550
Figure 2. Schematic diagram of MXene-based biomimetic plasmonic assembly for targeted cancer therapy [94].
Figure 2. Schematic diagram of MXene-based biomimetic plasmonic assembly for targeted cancer therapy [94].
Micromachines 13 01773 g002
Micromachines 13 01773 g003 550
Figure 3. Synthesis of 2D-ultrathin MXene/DOXjade platforms for targeted cancer therapy [95].
Figure 3. Synthesis of 2D-ultrathin MXene/DOXjade platforms for targeted cancer therapy [95].
Micromachines 13 01773 g003
Micromachines 13 01773 g004 550
Figure 4. A plausible mechanism of 2D-ultrathin MXene/DOXjade platform for cancer therapy [95].
Figure 4. A plausible mechanism of 2D-ultrathin MXene/DOXjade platform for cancer therapy [95].
Micromachines 13 01773 g004
Micromachines 13 01773 g005 550
Figure 5. (A) Schematic diagram of Ti3C2 nanosheet-based camouflaged bionic cascaded-enzyme nanoreactor. (B) The possible mechanism of action for the designed MXene-based camouflaged bionic cascaded-enzyme nanoreactor (in vivo) [100].
Figure 5. (A) Schematic diagram of Ti3C2 nanosheet-based camouflaged bionic cascaded-enzyme nanoreactor. (B) The possible mechanism of action for the designed MXene-based camouflaged bionic cascaded-enzyme nanoreactor (in vivo) [100].
Micromachines 13 01773 g005
Micromachines 13 01773 g006 550
Figure 6. A schematic diagram of FNC inhibited inflammation and osteoclastogenesis. (A) Local injection of FNC at osteolytic sites. (B) Materials interaction between macrophages and osteoclasts influenced inflammation and osteoclastogenesis. (C) FNC was phagocytosed, and FNC exhibited the effect of ROS adsorption. Subsequently, the inflammatory and osteoclast-specific genes were down-regulated [101].
Figure 6. A schematic diagram of FNC inhibited inflammation and osteoclastogenesis. (A) Local injection of FNC at osteolytic sites. (B) Materials interaction between macrophages and osteoclasts influenced inflammation and osteoclastogenesis. (C) FNC was phagocytosed, and FNC exhibited the effect of ROS adsorption. Subsequently, the inflammatory and osteoclast-specific genes were down-regulated [101].
Micromachines 13 01773 g006
Micromachines 13 01773 g007 550
Figure 7. (A) Pictorial representation for the working mechanism of CGDSTC nanosheets. (B) The preparative process of CGDSTC nanosheets [33].
Figure 7. (A) Pictorial representation for the working mechanism of CGDSTC nanosheets. (B) The preparative process of CGDSTC nanosheets [33].
Micromachines 13 01773 g007
Micromachines 13 01773 g008 550
Figure 8. The preparative process of MXene quantum dot/ZIF-based systems for anticancer drug delivery [97].
Figure 8. The preparative process of MXene quantum dot/ZIF-based systems for anticancer drug delivery [97].
Micromachines 13 01773 g008
Micromachines 13 01773 g009 550
Figure 9. The preparation of few-layer Ti3C2Tx MXene nanosheets with high chemical stability using an IL-assisted exfoliating (red patterns) method for photoacoustic imaging-guided synergistic photothermal/chemotherapy of tumors [104].
Figure 9. The preparation of few-layer Ti3C2Tx MXene nanosheets with high chemical stability using an IL-assisted exfoliating (red patterns) method for photoacoustic imaging-guided synergistic photothermal/chemotherapy of tumors [104].
Micromachines 13 01773 g009
Micromachines 13 01773 g010 550
Figure 10. The preparative process and function of designed MXenes for cancer nanotherapy [106].
Figure 10. The preparative process and function of designed MXenes for cancer nanotherapy [106].
Micromachines 13 01773 g010
Table
Table 1. Different MXene-based systems for cancer therapy.
Table 1. Different MXene-based systems for cancer therapy.
FormulationsTargeted Tissue/OrganAdvantages/BenefitsBiocompatibility and ToxicityRef.
Nb2C-Pt-DOX@MSkinBiomimetic plasmonic assembly completed the tumor treatment by irradiation of NIR-II, as a novel strategy to promote the nanozyme biocatalyst and plasmonic application in tumors.Bioplasmonic assembly of biocatalyst[94]
DOXjade-loaded Ti3C2-PVPSkinA pH-responsive dual-therapeutic compound based on federation and DOX, was created wherein photo-irradiation with Ti3C2-PVP@DOXjade displayed a pH-responsive iron chelation/PTT/chemotherapy anticancer activity.Good biocompatibility and lower cytotoxicity[95]
MeTGCTSkinUnder NIR laser irradiation, Ti3C2 may create both heat and ROS, where heat can speed up the enzyme-catalyzed reaction rate and ROS generation, exacerbating the hypoxic state in the target TME.Good biocompatibility[100]
Few-layered Nb2C (FNC)boneFew-layered Nb2C (FNC) reduces UHMWPE and induced osteolysis.Good biocompatibility[101]
CGDSTC nanosheetsSkinIt was applied for glucose deprivation and photodynamic therapy for the cokilling of cancer cellsHigher
stability and biologically safe
under nonstimulus conditions		[33]
MXene quantum dot/ZIF-based systemsSkinDOX and MXene quantum dot (MQD) to furnish MQD@ZIF-8/DOX with high photothermal conversion efficacy and ROS generation abilityGood biocompatibility, used as a drug delivery platform.[97]
Few-layer Ti3C2Tx MXene nanosheetsSkinphotoacoustic imaging
and synergistic photothermal/chemotherapy of cancer.		Good solubility, nontoxicity[104]
MXene@Au-polyethylene glycol compositesSkinImproved photothermal stability, biosafety, and histocompatibility during in vivo and vitro tests.Good biocompatibility[106]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Mohajer, F.; Ziarani, G.M.; Badiei, A.; Iravani, S.; Varma, R.S. Advanced MXene-Based Micro- and Nanosystems for Targeted Drug Delivery in Cancer Therapy. Micromachines 2022, 13, 1773. https://doi.org/10.3390/mi13101773

AMA Style

Mohajer F, Ziarani GM, Badiei A, Iravani S, Varma RS. Advanced MXene-Based Micro- and Nanosystems for Targeted Drug Delivery in Cancer Therapy. Micromachines. 2022; 13(10):1773. https://doi.org/10.3390/mi13101773

Chicago/Turabian Style

Mohajer, Fatemeh, Ghodsi Mohammadi Ziarani, Alireza Badiei, Siavash Iravani, and Rajender S. Varma. 2022. "Advanced MXene-Based Micro- and Nanosystems for Targeted Drug Delivery in Cancer Therapy" Micromachines 13, no. 10: 1773. https://doi.org/10.3390/mi13101773

APA Style

Mohajer, F., Ziarani, G. M., Badiei, A., Iravani, S., & Varma, R. S. (2022). Advanced MXene-Based Micro- and Nanosystems for Targeted Drug Delivery in Cancer Therapy. Micromachines, 13(10), 1773. https://doi.org/10.3390/mi13101773

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop